1. Home
  2. ZLAB vs DHT Comparison

ZLAB vs DHT Comparison

Compare ZLAB & DHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zai Lab Limited

ZLAB

Zai Lab Limited

N/A

Current Price

$24.14

Market Cap

2.6B

Sector

Health Care

ML Signal

N/A

Logo DHT Holdings Inc.

DHT

DHT Holdings Inc.

N/A

Current Price

$22.00

Market Cap

2.9B

ML Signal

N/A

Company Overview

Basic Information
Metric
ZLAB
DHT
Founded
2013
2005
Country
China
Bermuda
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Marine Transportation
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.9B
IPO Year
2017
2005

Fundamental Metrics

Financial Performance
Metric
ZLAB
DHT
Price
$24.14
$22.00
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
3
Target Price
$49.60
$19.33
AVG Volume (30 Days)
1.0M
3.2M
Earning Date
05-07-2026
05-05-2026
Dividend Yield
N/A
5.36%
EPS Growth
38.46
N/A
EPS
N/A
N/A
Revenue
$460,156,000.00
N/A
Revenue This Year
$9.75
$8.85
Revenue Next Year
$26.03
N/A
P/E Ratio
N/A
$12.73
Revenue Growth
15.33
N/A
52 Week Low
$15.96
$10.83
52 Week High
$34.72
$21.29

Technical Indicators

Market Signals
Indicator
ZLAB
DHT
Relative Strength Index (RSI) 47.84 69.73
Support Level $16.84 $17.35
Resistance Level $27.22 N/A
Average True Range (ATR) 0.81 0.63
MACD -0.40 0.16
Stochastic Oscillator 16.06 94.77

Price Performance

Historical Comparison
ZLAB
DHT

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.

About DHT DHT Holdings Inc.

DHT Holdings Inc is a crude oil tanker company. The company's primary business is operating a fleet of crude oil tankers, with a secondary activity of providing technical management services. Its fleet trades internationally and consists of VLCC crude oil tankers. The group generates revenues from time charter and spot market operations. It operates vessels through its subsidiary management companies in Monaco, Norway, Singapore, and India. The company generates the majority of its revenue from Voyage charter revenues.

Share on Social Networks: